Owkin uses federated learning to train AI models on hospital data without moving it — for biomarker discovery, drug development, and patient stratification. Strategic partnerships with Sanofi, BMS. Paris + NYC HQ. Founded by Thomas Clozel and Gilles Wainrib.
How Owkin compares with its closest alternatives
1 of the 5 closest alternatives has a free plan; Owkin does not. 2 of the 5 offer an API; FalcoScan's records show none for Owkin. Owkin offers a web app. Of the alternatives, 4 offer a web app. Owkin was founded in 2016; the alternatives were founded between 2013 and 2022, 2 of them earlier. Owkin is based in Paris, France; none of its 5 alternatives is in France. They are in South Korea, India, Sweden and elsewhere.
Market position · Healthcare
How Owkin compares in Healthcare
Owkin has high opportunity and sits in the bottom third of 250 live Healthcare tools on FalcoScan. Across Healthcare, the average opportunity score is 83.2 and the average saturation score 11.1. FalcoScan rates Owkin's own market position as open. 87 of the 250 operating Healthcare tools have hot momentum, and FalcoScan has recorded 8 shutdowns in the category.
The closest alternatives to Owkin that are still running, matched on the AI capabilities, uses and audience they share, are Lunit, Niramai, Kry, SAKAK, and Bitfount.
Is Owkin still running?
Yes. As of 2 November 2026, FalcoScan lists Owkin as operating at owkin.com.
Where is Owkin based?
Owkin is headquartered in Paris, France.
Does Owkin have an API?
FalcoScan's records show no public API for Owkin.
Who is Owkin for?
Owkin is built for enterprises, pharma, and healthcare providers.
How do I sign in to Owkin?
Sign in on Owkin's own website, owkin.com. FalcoScan reviews Owkin but does not run its accounts, so logins, passwords and billing are handled by Owkin directly.